Farr Miller & Washington’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.06M | Buy |
9,814
+43
| +0.4% | +$4.91K | 0.07% | 97 |
|
|
2021
Q2 | $1.1M | Hold |
9,771
| – | – | 0.07% | 95 |
|
|
2021
Q1 | $1.06M | Buy |
9,771
+22
| +0.2% | +$2.35K | 0.07% | 93 |
|
|
2020
Q4 | $1.04M | Buy |
9,749
+400
| +4% | +$38.4K | 0.08% | 91 |
|
|
2020
Q3 | $819K | Buy |
9,349
+22
| +0.2% | +$2.07K | 0.07% | 92 |
|
|
2020
Q2 | $916K | Buy |
9,327
+12
| +0.1% | +$1.06K | 0.07% | 83 |
|
|
2020
Q1 | $710K | Buy |
9,315
+50
| +0.5% | +$4.26K | 0.07% | 82 |
|
|
2019
Q4 | $820K | Hold |
9,265
| – | – | 0.06% | 87 |
|
|
2019
Q3 | $702K | Buy |
9,265
+200
| +2% | +$13.7K | 0.06% | 90 |
|
|
2019
Q2 | $659K | Hold |
9,065
| – | – | 0.05% | 86 |
|
|
2019
Q1 | $731K | Sell |
9,065
-73
| -0.8% | -$5.97K | 0.06% | 77 |
|
|
2018
Q4 | $842K | Sell |
9,138
-662
| -7% | -$58.2K | 0.08% | 71 |
|
|
2018
Q3 | $927K | Sell |
9,800
-200
| -2% | -$19K | 0.08% | 69 |
|
|
2018
Q2 | $926K | Sell |
10,000
-155
| -2% | -$15.1K | 0.08% | 68 |
|
|
2018
Q1 | $961K | Sell |
10,155
-100
| -1% | -$11K | 0.09% | 71 |
|
|
2017
Q4 | $992K | Hold |
10,255
| – | – | 0.09% | 68 |
|
|
2017
Q3 | $911K | Sell |
10,255
-1,083
| -10% | -$82.4K | 0.09% | 69 |
|
|
2017
Q2 | $822K | Buy |
11,338
+1,032
| +10% | +$69.4K | 0.08% | 73 |
|
|
2017
Q1 | $672K | Sell |
10,306
-300
| -3% | -$18.9K | 0.07% | 72 |
|
|
2016
Q4 | $664K | Sell |
10,606
-800
| -7% | -$48.8K | 0.07% | 72 |
|
|
2016
Q3 | $719K | Sell |
11,406
-727
| -6% | -$47.1K | 0.08% | 71 |
|
|
2016
Q2 | $751K | Buy |
12,133
+3,991
| +49% | +$243K | 0.08% | 69 |
|
|
2016
Q1 | $465K | Sell |
8,142
-100
| -1% | -$5.57K | 0.05% | 78 |
|
|
2015
Q4 | $488K | Hold |
8,242
| – | – | 0.06% | 78 |
|
|
2015
Q3 | $448K | Sell |
8,242
-50
| -0.6% | -$3.25K | 0.06% | 80 |
|
|
2015
Q2 | $557K | Sell |
8,292
-191
| -2% | -$12.5K | 0.06% | 76 |
|
|
2015
Q1 | $497K | Sell |
8,483
-7,600
| -47% | -$459K | 0.06% | 75 |
|
|
2014
Q4 | $1.05M | Hold |
16,083
| – | – | 0.12% | 62 |
|
|
2014
Q3 | $929K | Sell |
16,083
-450
| -3% | -$25K | 0.12% | 62 |
|
|
2014
Q2 | $933K | Sell |
16,533
-700
| -4% | -$36.7K | 0.12% | 62 |
|
|
2014
Q1 | $886K | Sell |
17,233
-2,019
| -10% | -$102K | 0.12% | 61 |
|
|
2013
Q4 | $1.02M | Buy |
19,252
+2,019
| +12% | +$99.2K | 0.14% | 58 |
|
|
2013
Q3 | $771K | Sell |
17,233
-1,050
| -6% | -$46.5K | 0.12% | 62 |
|
|
2013
Q2 | $756K | Buy |
+18,283
| New | +$800K | 0.12% | 62 |
|
Other funds holding ABBV
Farr Miller & Washington's ABBV Position: Q3 2021 in Review
Farr Miller & Washington increased its AbbVie (ABBV) stake by 0.44% in Q3 2021, buying an estimated $4.91K and bringing the position to 9,814 shares worth $1.06M. The position accounts for 0.07% of the portfolio, ranked #97.
Farr Miller & Washington first reported a position in ABBV in Q2 2013 and has held it in 34 quarters since. The position peaked at $1.1M in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.
- Farr Miller & Washington held 9,814 shares of AbbVie worth $1.06M as of Q3 2021.
- Farr Miller & Washington bought 43 AbbVie shares in Q3 2021, an estimated $4.91K.
- AbbVie made up 0.07% of Farr Miller & Washington's portfolio in Q3 2021, its #97 holding.
- Farr Miller & Washington first reported a position in AbbVie in Q2 2013 and has held it in 34 quarters since.
- Farr Miller & Washington's AbbVie position peaked at $1.1M in Q2 2021.
- 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.